R. Polosa (Catania, Italy), G. Joos (Gent, Belgium)
Spontaneous, Fas- and glucocorticoid (GC)-mediated lymphocyte apoptosis in atopic bronchial asthma(ABA): mechanisms, role in pathogenesis and therapy
S. V. Boichuk, I. G. Mustafin, R. S. Fassakhov, D. V. Tereshenko (Kazan, Russia)
|  |
Impared endotoxin-induced Interleukin (IL) -5 and Interferon- (IFN) γ expression in peripheral blood T-lymphocytes from atopic asthmatics
D. Rottlaender, E. Klein, A. Koch (Cologne, Germany)
| |
Bronchial hyperreactivity, atopy and wheezing in asthma diagnostics
J. B. Minov, J. D. Karadzinska-Bislimovska, K. V. Vasilevska, S. M. Ristevska-Kuc, S. M. Stoleski (Skopje, Macedonia)
| |
Granule protein changes and membrane receptor phenotype in maturing human eosinophils cultured from CD34+ progenitors
M. W. Al-Rabia, M. G. Blaylock, D. W. Sexton, G. M. Walsh (Aberdeen, United Kingdom)
| |
Ciliary beat frequency following allergen exposure in vitro
T. Stein, M. Y. Abdel-Aziz, I. Wissen-Siegert, H. L. Hahn (Wiesbaden, Germany)
| |
Influence of inhaled steroids on serum interleukin-5 and interleukin-13 in an adult population of stable asthmatics
J. Joseph, S. Benedict, W. Safa, M. Joseph, S. Abdulkhalik (Al Ain, United Arab Emirates)
| |
Correlation of high eosinophilic cathionic protein (ECP) levels with allergy parameters
B. Gemicioglu, B. Musellim, K. Guven, N. Yilmaz (Istanbul, Turkey)
| |
The role of ECP, IL-4 and IL-5 in asthmatic patients
Z. M. Goseva, A. S. Gjorcev, D. V. Dokic, Z. S. Arsovski (Skopje, Macedonia)
| |
Eosinophilic cationic protein in relation to different clinical types of bronchial asthma
M. M. Zedan, F. A. Elchenawy, T. E. Abd Elgalil, N. A. Nasef (Mansoura, Egypt)
| |
Homogenisation of induced sputum with N-acetyl-L-cysteine (NAC) is protective for sputum cells
F. J. van Overveld, U. A. Demkow, D. Górecka, E. Skopinska-Rozewska, W. A. De Backer, J. Zielinski (Antwerp, Belgium; Warsaw, Poland)
| |
Exhaled nitric oxide is significantly affected by small changes in airway calibre induced by methacholine in asthmatic subjects
A. Di Franco, A. Di Paco, A. Guerra, M. Tonelli, M. Taccola, M. De Santis, E. Masino, E. Bacci, P. Paggiaro (Pisa, Italy)
| |
Exhaled nitric oxide and its short- and long-term variation in health non-smoking subjects
M. Andersson, K. Toren, A. C. Olin (Gothenburg, Sweden)
| |
Thromboxane in exhaled breath condensate in healthy volunteers and in patients with asthma
E. Huszár, G. Vass, I. Herjavecz, I. Horváth (Budapest, Hungary)
| |
Comparison of mediator levels in exhaled breath condensate obtained through tracheostomy or orally
G. Vass, E. Huszár, E. Barát, D. Kiss, I. Pénzes, M. Kollai, I. Horváth (Budapest, Hungary)
| |
Allergy to formaldehyde. Case report
Z. Adamowicz, A. Doboszynska, A. Siemieniuk, I. Tomaszewska (Warsaw, Poland)
| |
Allergy induced by Ambrosia e. pollen in southern Croatia
S. Cvitanovic, Z. Ivancevic, T. Konsa, D. Perisic, I. Gudelj (Split, Croatia)
| |
Protective effect of chronic opisthorchiasis in asthma
T. A. Evdokimova, L. M. Ogorodova (Tomsk, Russia)
| |
Hymenoptera venom immunoterapy – self experience (1995-2002)
I. Wojciechowska, M. Kulus (Warsaw, Poland)
| |